As World Down Syndrome Day approaches on March 21, 2025, the Canadian Down Syndrome Society (CDSS) is launching It Was Never ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.

Understanding fiber's role in nutrition reveals its potential in preventing chronic diseases, improving gut health, and reducing colorectal cancer risk.

With the rising prevalence of methicillin-resistant Staphylococcus (S.) aureus (MRSA), a multi drug resistant strain, treatment has become a ...

The authors commented that the patient’s "age, relative acute onset, and lack of medical history make this an atypical ...

INAB READ THE FULL INAB RESEARCH REPORT Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc ...

Bristol Myers Squibb gets European Commission approval to expand use of CAR T cell therapy, Breyanzi for relapsed or refractory follicular lymphoma: Princeton, New Jersey Monday, ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

Time is a scarce resource at the doctor’s office, with the average visit lasting nearly 19 minutes, according to 2023 ...

Postbiotics, derived from beneficial microbes, improve gut health by enhancing barrier function and immune responses, ...

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...